Clinical trial

Effect of Tocopherol and Ascorbic Acid on Neuroinflammation Markers Associated With Neuropeptide Expression in the AgRP/NPY and POMC Pathways in Mexican Population With Obesity

NCT07782411

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIETARY_SUPPLEMENT · Unmapped registry intervention Ascorbic acid (Vitamin C) Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention tocopherol alpha Find medicine records · Find other trials using this name

COMBINATION_PRODUCT · Unmapped registry intervention Ascorbic acid + tocopherol alpha Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effect of Tocopherol and Ascorbic Acid on Neuroinflammation Markers Associated With Neuropeptide Expression in the AgRP/NPY and POMC Pathways in Mexican Population With Obesity

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-08-10

PhaseNA

Conditions

Obesity (BMI>30)unresolved

Neuroinflammationunresolved

Interventions

Ascorbic acid (Vitamin C)DIETARY_SUPPLEMENT

tocopherol alphaDIETARY_SUPPLEMENT

Ascorbic acid + tocopherol alphaCOMBINATION_PRODUCT

Sponsors & collaborators

Autonomous University of Moreloslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07782411 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.